Trials / Conditions / Recurrent Adult Non-Hodgkin Lymphoma

Recurrent Adult Non-Hodgkin Lymphoma

7 registered clinical trials studyying Recurrent Adult Non-Hodgkin Lymphoma.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Trans NCT02797470	AIDS Malignancy Consortium	Phase 1 / Phase 2
Terminated	Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HS NCT02728700	Stanford University	Phase 1
Completed	Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma NCT01466881	National Cancer Institute (NCI)	Phase 2
Completed	Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients NCT01008462	Fred Hutchinson Cancer Center	Phase 2
Completed	Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukem NCT00897325	Children's Oncology Group	—
Completed	Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Tr NCT00027820	Fred Hutchinson Cancer Center	Phase 1 / Phase 2
Completed	High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patient NCT01177371	Case Comprehensive Cancer Center	Phase 2